ConductScience.org, home

Paper3202902

A new cytotoxic, DNA interstrand crosslinking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in Walker carcinoma cells.

Knox RJ and 3 others. Biochem Pharmacol, 1988. Cited by 148 papers, by iCite.

Cite this record

ConductScience Library. A new cytotoxic, DNA interstrand crosslinking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in Walker carcinoma cells. Papers, record 3202902. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3202902

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A new cytotoxic, DNA interstrand crosslinking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in Walker carcinoma cells.
PubMed
Journal
Biochem Pharmacol
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
148
iCite
Relative citation ratio, by iCite
4.27
iCite
Revised in PubMed
2019-06-23
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Knox RJR J
2Friedlos FF
3Jarman MM
4Roberts JJJ J

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
AziridinesMajor topic
AzirinesMajor topic
Carcinoma 256, WalkerMajor topic
Cross-Linking ReagentsMajor topic
DNA DamageMajor topic
NitroreductasesMajor topic
OxidoreductasesMajor topic
Animals
Cell Survival
Cricetinae
NAD
Rats
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 148 citations.

PMIDTitleJournalYearIn PapersSource
42935498Gene therapy as an upcoming technique in the treatment of cancer: A cellular solution to a cellular problem.Mol Ther Oncol2026https://conductscience.org/library/papers/42935498PubMed
42465319Leveraging Homologous Recombination Deficiency via the Repositioned Prodrug CB1954.bioRxiv2026https://conductscience.org/library/papers/42465319PubMed
40940618Novel TdsD nitroreductase: characterization of kinetics and substrate specificity.Biotechnol Lett2025https://conductscience.org/library/papers/40940618PubMed
39368987Prodrug activation by 4,4'-bipyridine-mediated aromatic nitro reduction.Nat Commun2024https://conductscience.org/library/papers/39368987PubMed
37067816The dinitrobenzamide mustard prodrugs, PR-104A and SN27686, for use in a novel MNDEPT cancer prodrug therapy approach.Biosci Rep2023https://conductscience.org/library/papers/37067816PubMed
37047605The Crystal Structure of Engineered Nitroreductase NTR 2.0 and Impact of F70A and F108Y Substitutions on Substrate Specificity.Int J Mol Sci2023https://conductscience.org/library/papers/37047605PubMed
34163368Engineering the Escherichia coli Nitroreductase NfsA to Create a Flexible Enzyme-Prodrug Activation System.Front Pharmacol2021https://conductscience.org/library/papers/34163368PubMed
33276631NRF2 and the Ambiguous Consequences of Its Activation during Initiation and the Subsequent Stages of Tumourigenesis.Cancers (Basel)2020https://conductscience.org/library/papers/33276631PubMed
32979040Evaluation of two xenobiotic reductases from Pseudomonas putida for their suitability for magnetic nanoparticle-directed enzyme prodrug therapy as a novel approach to cancer treatment.Microbiologyopen2020https://conductscience.org/library/papers/32979040PubMed
32093290Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model.Int J Mol Sci2020https://conductscience.org/library/papers/32093290PubMed
30773488Dual Inhibition of GSK3β and CDK5 Protects the Cytoskeleton of Neurons from Neuroinflammatory-Mediated Degeneration In Vitro and In Vivo.Stem Cell Reports2019https://conductscience.org/library/papers/30773488PubMed
30695061Regeneration of the zebrafish retinal pigment epithelium after widespread genetic ablation.PLoS Genet2019https://conductscience.org/library/papers/30695061PubMed
29785241An In Vivo Zebrafish Model for Interrogating ROS-Mediated Pancreatic β-Cell Injury, Response, and Prevention.Oxid Med Cell Longev2018https://conductscience.org/library/papers/29785241PubMed
27502282Functional Annotation of a Presumed Nitronate Monoxygenase Reveals a New Class of NADH:Quinone Reductases.J Biol Chem2016https://conductscience.org/library/papers/27502282PubMed
25853312Potent and tumor specific: arming bacteria with therapeutic proteins.Ther Deliv2015https://conductscience.org/library/papers/25853312PubMed
24732092Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo.Oncotarget2014https://conductscience.org/library/papers/24732092PubMed
24202330The Flavin Reductase MsuE Is a Novel Nitroreductase that Can Efficiently Activate Two Promising Next-Generation Prodrugs for Gene-Directed Enzyme Prodrug Therapy.Cancers (Basel)2013https://conductscience.org/library/papers/24202330PubMed
23542552The nitroreductase system of inducible targeted ablation facilitates cell-specific regenerative studies in zebrafish.Methods2013https://conductscience.org/library/papers/23542552PubMed
22914496Dual-therapeutic reporter genes fusion for enhanced cancer gene therapy and imaging.Gene Ther2013https://conductscience.org/library/papers/22914496PubMed
22365330Cellular senescence and cancer chemotherapy resistance.Drug Resist Updat2012https://conductscience.org/library/papers/22365330PubMed

See all 37 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3202902

GET https://conductscience.org/api/papers/v1/3202902/cited_by?page=2